KEGG ID | Description | KEGG Pathway | miRNAs |
K04355 | dnf, brain derived neurophic factor | Neurotrophin signaling pathway | miR-15b, miR-195, miR-30c; |
K02161 | Bcl2, B-cell CLL/lymphoma 2 | Apoptosis | miR-195, miR-23b, miR-23a, miR-34c, miR-15b, miR-125b-5p, miR-125a-5p; |
K05209 | Grin2a, glutamate receptor, N-methyl D-aspartate 2A | Long term potentiation | miR-125a-5p, miR-125b-5p, miR-30c; |
K05208 | Grin1,glutamate receptor | Long term potentiation | miR-15b, miR-195; |
K04144 | Drd1, dopamine receptor D1A | Dopaminergic synapse | miR-15b, miR-106b, miR-195; |
K07828 | Rhoq, ras homolog family member Q | Long term potentiation | miR-125a-5p, miR-125b-5p, miR-9; |
K04500 | Smad3, SMAD family member 3 | TGF-beta signaling pathway | miR-23a, miR-15b, miR-23b, miR-9, miR-195, miR-101b; |
K13376 | Tgfb2, transforming growth factor, beta 2 | TGF-beta signaling pathway | miR-23a, miR-23b; |
K04674 | TGFBR1, transforming growth factor | TGF-beta signaling pathway | miR-101b, miR-9, miR-128; |
K04603 | Grm1, glutamate receptor, metabotropic 1 | Long term potentiation | miR-101b; |
K04604 | Grm5, glutamate receptor, metabotropic 5 | Long term potentiation | miR-23a, miR-23b, miR-30c. |